The disclosure relates to screw-ups that occurred or so a decade ago, but has greatly embarrassed Glaxo, which trotted egress an exec who told 60 Minutes that he hopes such gaffes will neer happen again. And in this statement, Glaxo disputes any patients were harmed. Nonetheless, the settlement indicates the feds are now pursuing manufacturing fraud as aggressively as off-label marketing.
And this is not the final chapter; as we reported previously, the US Attorney in Boston says the investigation is ongoing.
http://www.pharmalot.com/2011/01/glaxo-whistleblower-the-worst-thing-i-ever-saw/
GlaxoSmithKline pays $ 750 Million for manufacturing fraud.
In a move that signals federal prosecutors are pursuing yet some other type of fraud in the pharmaceutical industry, GlaxoSmithKline has agreed to pay a whopping $750 million fine to settle charges everyplace numerous production problems contaminated meds, mislabeled packaging and incorrect dosages at a facility in Cidra, Puerto Rico.
The fine includes a $150 million criminal penalty and the remaining $600 million will be used to settle civil charges, as well cover the cost...If you want to get a profuse essay, order it on our website: Orderessay
If you want to get a full essay, wisit our page: write my essay .



0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.